A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age-Reference-Cited by-同舟云学术

A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age

Published:2019-09 Issue:9 Volume:38 Page:e209-e215
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Eun Byung Wook,Lee Taek Jin,Lee Jina,Kim Ki Hwan,Kim Dong Ho,Jo Dae Sun,Shin Sun Hee,Kim Hun,Kim Kyung-Ho,Kim Yun-Kyung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference15 articles.

1. The rationale for quadrivalent influenza vaccines.;Ambrose;Hum Vaccin Immunother,2012

2. Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine.;Chan;Expert Rev Vaccines,2012

3. Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): a randomized, double-blind, multi-center, phase 3 clinical trial.;Song;Vaccine,2015

4. A randomized, double-blind, active-controlled clinical trial of a cell culture-derived inactivated trivalent influenza vaccine (NBP607) in healthy children 6 months through 18 years of age.;Oh;Pediatr Infect Dis J,2018

5. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): a randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects.;Choi;Hum Vaccin Immunother,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-2779-x, a Key microRNA that is Related to the Tumorigenicity of the MDCK Cell Line;2024-03-18

2. Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2023-08

3. Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age;Expert Review of Vaccines;2023-03

4. Efficacy of cell culture-derived influenza vaccines for children: A systematic review and meta-analysis;Journal of Pediatric Pulmonology;2023

5. Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review;Frontiers in Immunology;2021-10-06